A typical private plan will cover almost any medication that has a notice of compliance, so it would cover upwards of about 15,000 different drugs. A typical public program would cover less than half of that. That's the delta you tend to see.
What you will tend to see in the diabetic space in particular is that private plans will cover many of the more innovative, cutting-edge things things like weekly injections, fast-acting mealtime injections and insulin specifically for diabetic comas. These are things that are not covered by the public plan but that we do cover privately.
When we looked at the list that was published with this pharmacare act, we were concerned by how narrow it was. I think others have noted that too. The vast majority of Canadians have very robust plans that cover essentially everything in the market. We work really hard to make sure we're doing that in a sustainable way, and we know they don't want to see that put at risk with any new government programs.